Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A

Tubercle and Lung Disease

Volumn 79, Issue 4, 1999, Pages 251-259

  Baldwin, S L ^b   D'Souza, C D ^a   Orme, I M ^a   Liu, M A ^b   Huygen, K ^c   Denis, O ^c   Tang, A ^d   Zhu, L ^d   Montgomery, D ^d   Ulmer, J B ^b  

^a Immunology and Pathology   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; INFECTION PREVENTION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 0032829622     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1054/tuld.1998.0196     Document Type: Article

References (48)

1. Huygen K, Content J, Denis O. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Med. 2:1996;893-898.
2. Ten Dam H G. Research on BCG vaccinination. Adv Tuberc Res. 21:1984;79-106.
3. Bourne N, Stanberry L R, Berstein D I, Lew D. DNA immunization against experimental genital herpes simplex virus infection. J Infect Dis. 173:1996;800-807.
4. Kriesel J D, Spruance S L, Daynes R A, Araneo B A. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex type 2 disease. J Infect Dis. 173:1996;536-541.
5. Manickan E, Rouse R J, Yu Z, Wire W S, Rouse B T. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J Immunol. 155:1995;259-265.
6. McClements W L, Armstrong M E, Keys R D, Liu M A. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus 2 disease. Proc Natl Acad Sci. 93:1996;11414-11420.
7. Rouse R J, Nair S K, Lydy S L, Bowen J C, Rouse B T. Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins. J Virol. 68:1994;5685-5689.
8. Davis H L, Michel M-L, Whalen R G. DNA-based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Human Molecular Genetics. 2:1993;1847-1851.
9. Davis H L, Schirmbeck R, Reimann J, Whalen R G. DNA-mediated immunization in mice induces a potent MHC class 1-restricted cytotoxic T lymphocyte response to hepatitis B surface antigen. Human Gene Therapy. 6:1995;1447-1456.
10. Kuhober A, Pudollek H-P, Reifenberg K. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice-. J Immunol. 156:1996;3687-3695.
11. Mancini M, Hadchouel M, Davis H L, Whalen R G, Tiollais P, Michel M-L. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc Natl Acad Sci USA. 93:1996;12496-12501.
12. Michel M-L, Davis H L, Schleef M, Mancini M, Tiollais P, Whalen R G. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci USA. 92:1995;5307-5311.
13. Schirmbeck R, Bohm W, Ando K, Chisari F V, Reimann J. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in non-responder mice. J Virol. 69:1995;5929-5934.
14. Geissler M, Gesien A, Tokushige K, Wands J R. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol. 158:1997;1231-1237.
15. Inchauspe G, Vitvitski L, Major M E. Plasmid DNA expressing a secreted or nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol. 16:1997;185-195.
16. Lagging L M, Meyer K, Hoft D, Houghton M, Belshe R B, Ray R. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J Virol. 69:1995;5859-5863.
17. Major M E, Vitvitski L, Mink M A. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J Virol. 69:1995;5798-5805.
18. Tokushige K, Wakita T, Pachuk C. Expression an immune response to hepatitis C virus core DNA based vaccine constructs. Hepatology. 24:1996;14-20.
19. Boyer J D, Wang B, Ugen K E. In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. J Med Primatol. 25:1996;242-250.
20. Fuller D H, Haynes J R. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res Hum Retroviruses. 10:1994;1433-1441.
21. Wang B, Boyer J, Srikantan V. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biol. 12:1993;799-805.
22. Wang B, Ugen K E. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 90:1993;4156-4160.
23. Wang B, Boyer J, Srikantan V. Induction of humoral and cellular immune responses to the human immunodeficiency Type 1 virus in nonhuman primates in vivo DNA inoculation. Virology. 211:1995;102-112.
24. Xu D, Liew F Y. Genetic vaccination against leishmaniasis. Vaccine. 12:1994;1534-1536.
25. Xu D, Liew F Y. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein gp63 of L. major. Immunol. 84:1995;173-176.
26. Luke C J, Carner K, Liang X, Barbour A G. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. J Infect Dis. 175:1997;91-97.
27. Simon M M, Gern L, Hauser P. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter. Eur J Immunol. 26:1996;2831-2840.
28. Zhong W, Wiesmuller K H, Kramer M D, Wallich R, Simon M M. Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo. Eur J Immunol. 26:1996;2749-2757.
29. Lowrie D B, Tascon R E, Colston M J, Silva C L. Towards a DNA vaccine against tuberculosis. Vaccine. 12:1994;1537-1539.
30. Lowrie D B, Silva C L, Colston M J, Ragno S, Tascon R E. Protection against tuberculosis by a plasmid DNA vaccine. Vaccine. 15:1997;834-838.
31. Lozes E, Huygen K, Content J. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine. 15:1997;830-833.
32. Silva C L. New vaccines against tuberculosis. Braz J Med Biol Res. 28:1995;843-851.
33. Silva C L, Silva M F, Pietro R C, Lowrie D B. Characterization of T cells that confer a high degree of protective immunity against tuberculosis in mice after vaccination with tumor cells expressing hsp65. Infect Immun. 64:1996;2400-2407.
34. Tascon R E, Colston M J, Ragno S, Stavropoulos E, Gregory D, Lowrie D B. Vaccination against tuberculosis by DNA injection. Nat Med. 2:1996;888-892.
35. Zhu X, Venkataprasad N, Thangaraj H S. Functions and specificity of T Cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J Immunol. 158:1997;5921-5926.
36. Donnelly J J, Ulmer J B, Shiver J W, Liu M A. DNA vaccines [Review]. Ann Rev Immunology. 15:1997;617-648.
37. Belisle J T, Vissa V D, Sievert T, Takayama K, Brennan P J, Besra G S. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science. 276:1997;1420-1422.
38. Wiker H G, Harboe M. The Antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microb Reviews. 56:1992;648-661.
39. Denis O, Tanghe A, Palfliet K. Vaccination with plasmid DNA encoding antigen 85A stimulates a CD4+ and CD8+ T-Cell epitope repertoire broader than stimulated by M. tuberculosis H37Rv infection. Infect Immun. 66:1998;1527-1533.
40. Montgomery D L, Huygen K, Yawman A M. Induction of humoral and cellular immune responses by vaccination with M. tuberculosis antigen 85 DNA. Cell Mol Biol. 43:1997;285-292.
41. Ulmer J B, Liu M A, Montgomery D L. Expression and immunogenicity of M. tuberculosis antigen 85 by DNA vaccination. Vaccine. 15:1997;792-794.
42. Davis H L, Millan C L, Watkins S C. Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene-Ther. 4:1997;181-188.
43. Griffin, J, P, Orme, I, M, Evolution of CD4 T-cell subsets following infection of naive and memory immune mice with Mycobacterium tuberculosis, Infect Immun, 62, 1683, 1690.
44. Krieg A M, Yi A-K, Waldschmidt T J. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
45. Messina J P, Gilkeson G S, Pisetsky D S. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol. 147:1991;1759-1764.
46. Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E, Yano O, Tokunaga T. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J Immunol. 148:1992;4072-4076.
47. Orme I M, Collins F M. Adoptive protection of the Mycobacterium tuberculosis- infected lung: dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cellular Immunology. 84:1984;113-120.
48. Cooper A M, Dalton D K, Stewart T A, Griffin J P, Russel D G, Orme I M. Disseminated tuberculosis in interferon γ gene-disrupted mice. J Exp Med. 178:1993;2243-2247.